A Randomized, Multi-center, Parallel Group, Double Blind, Placebo and Formoterol Controlled 14 Day Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER Device in Adult and Adolescent Patients With Persistent Asthma.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Indacaterol (Primary) ; Formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 09 Jun 2012 Planned number of patients changed from 390 to 488 as reported by European Clinical Trials Database.
- 08 Apr 2009 Actual patient number (392) added as reported by ClinicalTrials.gov.
- 04 Jun 2008 Status changed from in progress to completed according to ClinicalTrials.gov.